Podiums⎪Recon⎪Evaluation of the Painful TKA in 2024 Deciding when to operate?

Podiums⎪Recon⎪Evaluation of the Painful TKA i...

Up next

Foundations | Pathology | Osteoid Osteoma

Welcome to Season 2 of the Orthobullets Podcast.Today's show is Foundations, where we review foundational knowledge for frontline MSK providers such as junior orthopaedic residents, ER physicians, and primary care providers. This episode will cover the topic of⁠⁠ ⁠⁠⁠Osteoid Osteo ...  Show more

Recon | THA Dislocation

Welcome to Season 2 of the Orthobullets Podcast.In this episode, we review the high-yield topic of ⁠⁠THA Dislocation⁠ ⁠from the Recon section.⁠Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ...  Show more

Recommended Episodes

Episode 072: Introduction to Diffuse Large B-Cell Lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease.

<p class="" style="white- ...  Show more

Preview of “The Blueprint” Season 2
Main Justice

Jen Psaki is on a mission to show us how the Democratic party can use this political moment to fight and win again. On Season 2 of her podcast, “The Blueprint,” she interviews the people reshaping the party, starting with Texas Congressman Greg Casar, Chair of the Progressive ...

  Show more

Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML
The Fellow on Call: The Heme/Onc Podcast

In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transp ...

  Show more

Episode 073: Management of Early Stage Diffuse Large B-Cell Lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease.

If you have not done so, we highly recommend you listen to our ...

  Show more